Autoantibody against caspase-3, an executioner of apoptosis, in patients with systemic sclerosis
- 29 July 2009
- journal article
- research article
- Published by Springer Nature in Rheumatology International
- Vol. 30 (7) , 871-878
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Autoantibody against peroxiredoxin I, an antioxidant enzyme, in patients with systemic sclerosis: possible association with oxidative stressRheumatology, 2007
- Structural and Kinetic Analysis of Caspase-3 Reveals Role for S5 Binding Site in Substrate RecognitionJournal of Molecular Biology, 2006
- Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosusCellular Immunology, 2006
- Serum levels of 8-isoprostane, a marker of oxidative stress, are elevated in patients with systemic sclerosisRheumatology, 2006
- Possible Role of Apoptosis in the Pathogenesis of Bleomycin-Induced SclerodermaJournal of Investigative Dermatology, 2004
- Conformational restrictions in the active site of unliganded human caspase‐3Journal of Molecular Recognition, 2003
- Function Blocking Autoantibodies Against Matrix Metalloproteinase-1 in Patients with Systemic SclerosisJournal of Investigative Dermatology, 2003
- Selective cleavage of nuclear autoantigens during CD95 (Fas/APO-1)-mediated T cell apoptosis.Journal of Experimental Medicine, 1996
- Antihistone Antibodies in Systemic SclerosisArthritis & Rheumatism, 1994
- Antihistone antibodies in patients with localized sclerodermaArthritis & Rheumatism, 1993